Potential concerns with ventoclax and Richter's transformation
The aims of the Genomics England CLL pilot
Information is key: why patients need to be empowered to learn about their disease
Overview of research in Waldenström’s macroglobulinemia therapies
Panel discussion on novel therapies and targets for lymphoma
John Gribben et al.